(Q35541862)

8 August 2017

title

Quality of care in patients with bladder cancer: a case report? (English)

1 reference

8 August 2017

0 references

1 reference

2

Christopher S Saigal

1 reference

8 August 2017

7

Mark S Litwin

1 reference

Urologic Diseases in America Project

8 August 2017

8

object named as

Urologic Diseases in America Project

1 reference

8 August 2017

3

Julie Lai

1 reference

8 August 2017

Karim Chamie

1

1 reference

8 August 2017

Jan M Hanley

4

1 reference

8 August 2017

Claude M Setodji

5

1 reference

8 August 2017

Badrinath R Konety

6

1 reference

8 August 2017

language of work or name

English

0 references

publication date

5 August 2011

1 reference

8 August 2017

1 reference

8 August 2017

volume

118

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

1412-1421

1 reference

8 August 2017

cites work

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Patterns of care for early stage bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Provider treatment intensity and outcomes for patients with early-stage bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

The quality of health care delivered to adults in the United States

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Adherence to Surveillance Among Patients With Superficial Bladder Cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213323

Development of a comorbidity index using physician claims data

27 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

Understanding the variation in treatment intensity among patients with early stage bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

Pay for Performance in Commercial HMOs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26402

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

21 January 2018

1 reference

12 December 2020

Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients

1 reference

12 December 2020

Intravesical instillation of mitomycin C in the prophylactic treatment of recurring superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial

1 reference

12 December 2020

Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times

1 reference

12 December 2020

Hematuria home screening: repeat testing results

1 reference

12 December 2020

The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up

1 reference

12 December 2020

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population

1 reference

12 December 2020

The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.26402

1 reference

8 August 2017

1 reference

8 August 2017

1 reference